Oragenics, Inc. (OGEN)

Oragenics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.86	3.48	11.43	27.27	17.64
Short-Term Investments	-	-	0.02	-	-
Cash & Short-Term Investments	0.86	3.48	11.44	27.27	17.64
Cash Growth	-75.17%	-69.56%	-58.03%	54.57%	-3.44%
Other Receivables	-	-	-	0.01	-
Receivables	-	-	-	0.01	-
Prepaid Expenses	0.43	0.38	0.37	0.43	0.34
Other Current Assets	0.18	-	2.47	-	-
Total Current Assets	1.47	3.87	14.29	27.71	17.98
Property, Plant & Equipment	-	0.01	0.47	0.52	0.7
Long-Term Deferred Charges	-	1.09	-	-	-
Total Assets	1.47	4.97	14.76	28.23	18.68
Accounts Payable	1.14	1.24	0.25	0.85	0.33
Accrued Expenses	0.21	0.23	0.88	0.09	0.61
Short-Term Debt	0.33	0.31	0.27	0.3	0.23
Current Portion of Leases	-	0.01	0.2	0.19	0.18
Total Current Liabilities	1.68	1.8	1.6	1.45	1.34
Long-Term Leases	-	-	0.15	0.3	0.49
Total Liabilities	1.68	1.8	1.75	1.74	1.84
Common Stock	0.01	0	0	0	0.09
Additional Paid-In Capital	216.56	207.79	196.98	195.1	164.02
Retained Earnings	-216.79	-206.22	-185.56	-171.27	-154.44
Total Common Equity	-0.21	1.58	11.42	23.83	9.67
Shareholders' Equity	-0.21	3.17	13.01	26.49	16.84
Total Liabilities & Equity	1.47	4.97	14.76	28.23	18.68
Total Debt	0.33	0.32	0.62	0.8	0.9
Net Cash (Debt)	0.54	3.16	10.82	26.47	16.74
Net Cash Growth	-83.03%	-70.79%	-59.12%	58.11%	-3.17%
Net Cash Per Share	0.08	1.41	5.39	13.62	17.77
Filing Date Shares Outstanding	21.48	4.48	2.02	1.94	1.83
Total Common Shares Outstanding	12.57	3.08	2.02	1.94	1.53
Working Capital	-0.21	2.07	12.69	26.26	16.64
Book Value Per Share	-0.02	0.51	5.64	12.28	6.32
Tangible Book Value	-0.21	1.58	11.42	23.83	9.67
Tangible Book Value Per Share	-0.02	0.51	5.64	12.28	6.32
Machinery	-	-	1	1.18	1.27
Leasehold Improvements	-	-	0.49	0.49	0.49

Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q